Loading…
Nutriband Inc. is projected to rise to $3.16 by 2027, a +13% move from its current price of $2.81. NTRB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.75 | $2.81 | $2.87 | -0.01% |
| Aug 6 | $2.73 | $2.81 | $2.90 | -0.01% |
| Aug 7 | $2.71 | $2.81 | $2.91 | -0.02% |
| Aug 8 | $2.69 | $2.81 | $2.93 | -0.02% |
| Aug 9 | $2.68 | $2.81 | $2.95 | -0.03% |
| Aug 10 | $2.67 | $2.81 | $2.96 | -0.03% |
| Aug 11 | $2.66 | $2.81 | $2.97 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.66 | $2.81 | $2.97 | -0.04% |
| Week 2 | $2.59 | $2.81 | $3.04 | -0.08% |
| Week 3 | $2.55 | $2.81 | $3.09 | -0.12% |
| Week 4 | $2.51 | $2.81 | $3.14 | -0.16% |
| Week 5 | $2.47 | $2.80 | $3.18 | -0.20% |
| Week 6 | $2.44 | $2.80 | $3.22 | -0.24% |
| Week 7 | $2.41 | $2.80 | $3.25 | -0.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain.
The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Nutriband Inc. (NTRB) is currently trading at $2.88 per share with a market capitalization of $35.01M. It is ranked 4693 in market size items.
The year-by-year forecast provides a long-run price path from 2026 to 2050, with near-term values tight around the current price and longer-term gains as the years progress. In 2026 the avg is $2.88 with a max of $3.45, and the outlook strengthens into the later years with a 2050 avg of $11.11 and a max of $18.91; the implied ROI grows from 0 in 2026 to 285.8 in 2050, with bullish sentiment emerging from 2028 onward.
A major floor 7.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.4% away) — a key level to hold.
The nearest ceiling, 14.2% above — a clean break opens room to run.
A major ceiling 53.0% above — clearing it would confirm fresh momentum.
Key NTRB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTRB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.92 | Sell | $2.91 | Sell |
| MA 10 | $2.97 | Sell | $2.95 | Sell |
| MA 20 | $3.01 | Sell | $3.01 | Sell |
| MA 50 | $3.21 | Sell | $3.21 | Sell |
| MA 100 | $3.53 | Sell | $3.56 | Sell |
| MA 200 | $4.30 | Sell | $4.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.40 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -145.93 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -6.56 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 30.94 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 2.87 | Sell |
| ADX (14) | 17.62 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL. RSI(14) is 40. The 50-day moving average sits at $3.23 and the 200-day moving average at $4.35.
Support is at $2.88 and resistance at $3.31. The 30-day price range runs from $2.50 to $3.32, and the stock shows moderate volatility with an annualized volatility of 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.81 | $2.81 | $3.36 | 0% | Neutral | |
| $2.57 | $3.16 | $4.08 | +13% | Neutral | |
| $2.73 | $3.43 | $4.56 | +22% | Bullish | |
| $2.93 | $3.75 | $5.09 | +33% | Bullish | |
| $2.91 | $3.77 | $5.24 | +34% | Bullish | |
| $2.78 | $3.66 | $5.16 | +30% | Bullish | |
| $2.99 | $3.98 | $5.71 | +42% | Bullish | |
| $3.00 | $4.04 | $5.88 | +44% | Bullish | |
| $3.26 | $4.45 | $6.55 | +58% | Bullish | |
| $3.78 | $5.22 | $7.79 | +86% | Bullish | |
| $4.28 | $6.20 | $9.74 | +121% | Bullish | |
| $7.13 | $11.21 | $19.01 | +299% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.81 | $2.81 | $3.35 | +0.00% |
| September 2026 | $2.43 | $2.86 | $3.44 | +1.71% |
| October 2026 | $2.37 | $2.80 | $3.39 | -2.20% |
| November 2026 | $2.28 | $2.70 | $3.30 | -3.26% |
| December 2026 | $2.29 | $2.73 | $3.36 | +1.02% |
Click any year to see its month-by-month NTRB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NTRB to range from $2.81 to $3.36 through 2026. The $2.81 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NTRB price prediction for 2027 points to an average of $3.16 (low $2.57, high $4.08) — a potential gain of +13% on today's $2.81. Price action looks broadly range-bound.
In 2028, NTRB is projected to trade between $2.73 and $4.56, averaging $3.43 — a potential gain of +22% from today's $2.81. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Nutriband Inc.'s 2029 outlook centres on $3.75, within a $2.93 to $5.09 range. That is up +9% on the projected 2028 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2030, NTRB could reach as high as $5.24, with a base case around $3.77 and support toward $2.91 — roughly +34% from $2.81. Buyers look set to stay in control over this stretch.
Expect NTRB to range from $2.78 to $5.16 through 2031. The $3.66 average target implies a +30% move from current prices. That is -3% versus the projected 2030 average. Momentum favours further upside here.
The NTRB price prediction for 2032 points to an average of $3.98 (low $2.99, high $5.71) — a potential gain of +42% on today's $2.81. Buyers look set to stay in control over this stretch.
In 2033, NTRB is projected to trade between $3.00 and $5.88, averaging $4.04 — a potential gain of +44% from today's $2.81. That is up +2% on the projected 2032 average. Momentum favours further upside here.
Nutriband Inc.'s 2034 outlook centres on $4.45, within a $3.26 to $6.55 range. That is up +10% on the projected 2033 average. That marks a +58% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NTRB could reach as high as $7.79, with a base case around $5.22 and support toward $3.78 — roughly +86% from $2.81. Momentum favours further upside here.
Expect NTRB to range from $4.28 to $9.74 through 2040. The $6.20 average target implies a +121% move from current prices. That is up +19% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NTRB price prediction for 2050 points to an average of $11.21 (low $7.13, high $19.01) — a potential gain of +299% on today's $2.81. Momentum favours further upside here.
Investing $1,000 in NTRB today (≈ 355.871886 NTRB) could be worth
$3,991.1
+$2,991.1 (+299%) by 2050 · US Dollar
Based on the average projected NTRB price of $11.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTRBwould be worth at today's price.
$1,000 invested in NTRB on Jul 31, 2025 (≈ 138.696254 NTRB) would be worth
$389.74
-$610.26 (-61.0%) today · 0.39× · US Dollar
Based on a NTRB entry price of $7.21 vs. today's $2.81.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.98 | $942.95 | -5.7% |
| 1 month ago | $3.09 | $909.39 | -9.1% |
| 3 months ago | $3.86 | $727.98 | -27.2% |
| 6 months ago | $4.69 | $599.15 | -40.1% |
| 1 year ago | $7.21 | $389.74 | -61.0% |
| All time (4.8y) ago | $5.74 | $489.75 | -51.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTRB forecast.
Our base-case forecast reaches $5.60 around 2040.
Implied market cap at $5.60: $68.07M
The multi-year forecast moves into a bullish trajectory after 2027, with the 2028 average at $3.48 and a bullish sentiment. By 2030 the avg price is $3.80 with a min of $2.93 and a max of $5.29, and the ROI is 32.1. The path continues higher through 2040, where the avg is $6.14, the min is $4.22, the max is $9.68, and the ROI is 113.1.
By 2050 the avg reaches $11.11 with a min of $7.03 and a max of $18.91, and the ROI is 285.8, with the sentiment remaining BULLISH.
Across the forecast, sentiment is BULLISH from 2028 onward, reflecting a sustained upside path despite the inherent uncertainty of forecasts. These figures are estimates and not guarantees, and actual results can differ due to market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an avg of $3.80 with a min of $2.93 and a max of $5.29; ROI is 32.1 and the sentiment is BULLISH.
The forecast path includes bullish sentiment from 2028 onward, with 2030 avg $3.80 and ROI 32.1, 2040 avg $6.14 with ROI 113.1, and 2050 avg $11.11 with ROI 285.8. These are estimates and not guarantees.
Yes. The 2050 max price is $18.91, and the 2040 max is $9.68, so the forecast allows for values above $10 by 2050.
Current price is $2.88 and market cap is $35.01M.
The 30-day range is from $2.50 to $3.32.
Nutriband Inc. Community Discussion
0Share your Nutriband Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.